N-(Benzo[d][1,3]dioxol-5-ylmethyl)-4-(1-(2-((3-chlorophenyl)amino)-2-oxoethyl)-2,4-dioxo-1,4-dihydroquinazolin-3(2H)-yl)butanamide
98%
- Product Code: 214776
CAS:
899937-47-4
| Molecular Weight: | 548.97 g./mol | Molecular Formula: | C₂₈H₂₅ClN₄O₆ |
|---|---|---|---|
| EC Number: | MDL Number: | MFCD14737591 | |
| Melting Point: | Boiling Point: | ||
| Density: | 1.419±0.06 g/cm3(Predicted) | Storage Condition: | 2-8°C, sealed, dry, light-proof |
Product Description:
Used in pharmaceutical research as a potent inhibitor of specific kinase enzymes involved in inflammatory pathways and cancer progression. Shows promising activity in modulating immune responses and suppressing tumor cell growth in preclinical models. Investigated for development in targeted therapies for autoimmune diseases and certain solid tumors. Its structure allows for high selectivity and binding affinity to ATP-binding sites of kinases, making it a valuable scaffold in drug design. Also employed in structure-activity relationship (SAR) studies to optimize potency and pharmacokinetic properties in novel therapeutic agents.
Sizes / Availability / Pricing:
| Size | Availability | Price | Quantity |
|---|---|---|---|
| 10mg | 10-20 days | ฿27,940.00 |
+
-
|
| 25mg | 10-20 days | ฿47,500.00 |
+
-
|
| 50mg | 10-20 days | ฿80,740.00 |
+
-
|
N-(Benzo[d][1,3]dioxol-5-ylmethyl)-4-(1-(2-((3-chlorophenyl)amino)-2-oxoethyl)-2,4-dioxo-1,4-dihydroquinazolin-3(2H)-yl)butanamide
Used in pharmaceutical research as a potent inhibitor of specific kinase enzymes involved in inflammatory pathways and cancer progression. Shows promising activity in modulating immune responses and suppressing tumor cell growth in preclinical models. Investigated for development in targeted therapies for autoimmune diseases and certain solid tumors. Its structure allows for high selectivity and binding affinity to ATP-binding sites of kinases, making it a valuable scaffold in drug design. Also employed in structure-activity relationship (SAR) studies to optimize potency and pharmacokinetic properties in novel therapeutic agents.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Purchase History for
Loading purchase history...
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :